← Research library

Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment

Randomized study in people · 1994

What was studied
162 adults aged 55 or older with age-associated memory impairment; 54 per arm; 135 completed
Main finding
Three-month randomized, double-blind trial compared two piracetam groups with placebo alongside memory training. Reported benefits depended on baseline performance and training timing.

Completed study · 135 overall; 45 per arm

Reported findings and study design

162 adults aged 55+ randomized into three groups of 54; piracetam 2.4 g, 4.8 g or placebo alongside cognitive training for three months; ten-day placebo washout.

Population or model 162 adults aged 55 or older with age-associated memory impairment; 54 per arm; 135 completed

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Completed study135 overall; 45 per arm
Non-completion27 overallCalculated from 162 enrolled minus 135 completed
Best reported combination4.8 g and training beginning after six weeksNo numerical memory-score effect size in abstract

Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Memory training is a co-intervention; this is not a drug-only comparison.
  • 27 participants did not complete; reasons and handling require full text.

Source details

Journal article

Europe PMC indexed abstract checked; complete trial methods not reviewed.

Abstract

Sources checked

Citation

Randomized trialEnglish abstract

Israel L, Melac M, Milinkevitch D, Dubos G. Drug therapy and memory training programs: a double-blind randomized trial of general practice patients with age-associated memory impairment International psychogeriatrics

Study source ↗ · DOI 10.1017/s1041610294001729 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards